Background: Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common in sub-Saharan Africa, despite reports of high levels of ART adherence in this setting. We sought to determine the relationship between very early ART adherence and early adverse outcomes in HIV-infected adults in Botswana. Methods: This prospective cohort study of 402 ART-naı̈ve, HIV-infected adults initiating ART at a public HIV clinic in Gaborone, Botswana evaluated the relationship between suboptimal early ART adherence and HIV treatment outcomes in the initial months after ART initiation. Early adherence during the interval between initial ART dispensation and first ART refill was calculated using pill counts. In the primary analysis p...
Development of HAART in the mid-1990’s and its continued scale up has revolutionized the treatment o...
Background: Adherence to antiretroviral therapy (ART) is a strong predictor of progression to AIDS a...
Botswana's AIDS response included free antiretroviral treatment (ART) since 2002, achieving 80% cove...
Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common in sub-Sah...
Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common in sub-Sah...
Background Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common...
Background Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common...
International audienceOBJECTIVE: To estimate the incidence and risk factors of mortality and severe ...
International audienceOBJECTIVE: To estimate the incidence and risk factors of mortality and severe ...
International audienceOBJECTIVE: To estimate the incidence and risk factors of mortality and severe ...
OBJECTIVES: To describe associations between different summaries of adherence in the first year on a...
OBJECTIVES: To describe associations between different summaries of adherence in the first year on a...
SummaryBackgroundShort-term mortality rates among patients with HIV receiving antiretroviral therapy...
Background: Short-term mortality rates among patients with HIV receiving antiretroviral therapy (ART...
OBJECTIVE: To analyse the early loss of patients to antiretroviral therapy (ART) programmes in resou...
Development of HAART in the mid-1990’s and its continued scale up has revolutionized the treatment o...
Background: Adherence to antiretroviral therapy (ART) is a strong predictor of progression to AIDS a...
Botswana's AIDS response included free antiretroviral treatment (ART) since 2002, achieving 80% cove...
Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common in sub-Sah...
Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common in sub-Sah...
Background Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common...
Background Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common...
International audienceOBJECTIVE: To estimate the incidence and risk factors of mortality and severe ...
International audienceOBJECTIVE: To estimate the incidence and risk factors of mortality and severe ...
International audienceOBJECTIVE: To estimate the incidence and risk factors of mortality and severe ...
OBJECTIVES: To describe associations between different summaries of adherence in the first year on a...
OBJECTIVES: To describe associations between different summaries of adherence in the first year on a...
SummaryBackgroundShort-term mortality rates among patients with HIV receiving antiretroviral therapy...
Background: Short-term mortality rates among patients with HIV receiving antiretroviral therapy (ART...
OBJECTIVE: To analyse the early loss of patients to antiretroviral therapy (ART) programmes in resou...
Development of HAART in the mid-1990’s and its continued scale up has revolutionized the treatment o...
Background: Adherence to antiretroviral therapy (ART) is a strong predictor of progression to AIDS a...
Botswana's AIDS response included free antiretroviral treatment (ART) since 2002, achieving 80% cove...